| Product Name | MF | CAS | Details |
|---|
| 2-(3-Formylphenyl)acetic acid | C9H8O3 | 34956-29-1 | Details |
| 1-{6-[(4-Bromophenyl)sulfanyl]pyridazin-3-yl}piperidine-3-carboxylic acid | C16H16BrN3O2S | 1112278-50-8 | Details |
| Contactin 2 antibody | Details |
| Mavezelimab | 2231068-83-8 | Details |
| 3-Butylpyridine | C9H13N | 539-32-2 | Details |
| Dichloromethane-d2 | CCl2D2 | 1665-00-5 | Details |
| 1,1,4,7,10,10-Hexamethyltriethylenetetramine | C12H30N4 | 3083-10-1 | Details |
| 1-(4-Fluorophenyl)-1H,4H,5H,6H-cyclopenta[C]pyrazol-3-amine hydrochloride | C12H13ClFN3 | 1909320-30-4 | Details |
| FHIT protein | Details |
| [5-FAM]-MPG?NLS | Details |
| 1-(3-methoxyphenyl)-3-((4-methylphenyl)sulfonyl)urea | C15H16N2O4S | 108838-88-6 | Details |
| 3-Methoxypyrazine-2-carbaldehyde | C6H6N2O2 | 63874-90-8 | Details |
| 6-Chloro-5-methyl-pyridine-3-sulphonyl chloride | C6H5Cl2NO2S | 37105-10-5 | Details |
| 2-Chloro-7-nitroquinoline | C9H5ClN2O2 | 49609-03-2 | Details |
| 2-chloro-3-((4-fluorophenyl)amino)cyclohex-2-en-1-one | C12H11ClFNO | 1023511-66-1 | Details |
| CDH4 antibody | Details |
| Phthalonitrile | C8H4N2 | 91-15-6 | Details |
| Phenyl 2,3,4,6-tetra-O-acetyl-b-D-thiogalactopyranoside | C20H24O9S | 24404-53-3 | Details |
| 7-[(tert-butoxy)carbonyl]-5H,6H,7H,8H-imidazo[1,5-a]pyrazine-1-carboxylic acid | C12H17N3O4 | 1160248-16-7 | Details |
| 1,3,2-Dioxaborolane, 2-(2,5-dichlorophenyl)-4,4,5,5-tetramethyl- | C12H15BCl2O2 | 479411-91-1 | Details |
| RPRD1B antibody | Details |
| [(2S)-1-Aminopropan-2-yl](2,2-difluoroethyl)amine dihydrochloride | C5H13ClF2N2 | 1799374-54-1 | Details |
| Zirconyl chloride hydrate | Cl2H2O2Zr | 15461-27-5 | Details |
| 2,2':6',2'-Terpyridine-4,4',4'-tricarboxylic acid | C18H11N3O6 | 216018-58-5 | Details |
| PPP1R2 protein (His tag) | Details |
| Prokineticin 2 protein | Details |
| Sodium tetradecyl sulphate | C14H31NaO4S | 1191-50-0 | Details |
| (S)-Hesperetin | C16H14O6 | 520-33-2 | Details |
| Benzyl-PEG2-azide | C11H15N3O2 | 1260001-87-3 | Details |
| 1-Butyl-3-methylimidazolium bromide | C8H15BrN2 | 85100-77-2 | Details |
| Fluvastatin sodium salt hydrate | C24H25FNO4.Na.H2O | 201541-53-9 | Details |
| H-AMMIARFKMFPEVKEKG-OH | Details |
| Ac-GITNIN-NH2 | Details |
| Naringenin 4',7-dimethyl ether | C17H16O5 | 29424-96-2 | Details |
| Ac-VLRLRGG-CHO | Details |
| 3,3'-Difluorobiphenyl | C12H8F2 | 396-64-5 | Details |
| Fmoc-L-Lys[Oct-(otBu)-Glu-(otBu)-AEEA-AEEA]-OH | C64H101N5O16 | 1662688-20-1 | Details |
| 2-Bromo-1-(1,3-dimethyl-1H-pyrazol-4-yl)ethan-1-one | C7H9BrN2O | 1311569-68-2 | Details |
| Methyl 2-bromo-3,3-dimethylbutanoate | C7H13BrO2 | 16495-40-2 | Details |
| CK1 antibody | Details |
| Dihydropunctatin | C20H26O7 | 49776-71-8 | Details |
| Tricaprylin | C27H50O6 | 538-23-8 | Details |
| mPEG5-CH2CH2COOH | Details |
| 17-Deoxy cortienic acid | C20H28O4 | 2394-25-4 | Details |
| (4-(Trifluoromethyl)phenyl)magnesium bromide - 0.25 M in THF | C7H4BrF3Mg | 402-51-7 | Details |
| Taxuspine B | C35H42O10 | 157414-05-6 | Details |
| 6-Methyl-4-(m-tolyl)-5-(3-(p-tolyl)-1,2,4-oxadiazol-5-yl)-3,4-dihydropyrimidine-2(1H)-thione | C21H20N4OS | 892302-22-6 | Details |
| 9-Cis-4-ketoretinol | C20H28O2 | 1076198-35-0 | Details |
| H-Ala-Ala-Ala-OMe acetate salt | C12H23N3O6 | 84794-58-1 | Details |
| VPS29 antibody | Details |
| 7-Bromo-2-methyl-1-benzothiophene | C9H7BrS | 75288-49-2 | Details |
| CRP Antibody, HRP | Details |
| (Ile3)-Pressinoic acid | C30H44N8O10S2 | 34330-23-9 | Details |
| Galectin 8 antibody | Details |
| ent-aprepitant | C23H21F7N4O3 | 172822-29-6 | Details |
| 3-(2-Iodoethyl)pyridine hydroiodide | C7H9I2N | 1864058-26-3 | Details |
| Histone H3.2 (1-44) | C109H185N39O29 | Details |
| RGS4 Blocking Peptide | Details |
| 3-(Ethoxycarbonyl)-1-methylcyclopentane-1-carboxylic acid | C10H16O4 | 1909336-36-2 | Details |
| C9ORF68 antibody | Details |
| Biotin-11-deoxycytidine-5'-triphosphate, lithium salt - 1 mM aqueous solution | C28H46N7O16P3S | 136632-30-9 | Details |
| 4-(4-Methanesulfonylphenoxy)aniline | C13H13NO3S | 284462-84-6 | Details |
| Adenosine 2',3'-cyclic monophosphate | C10H12N5O6P | 634-01-5 | Details |
| 3,3,4,4-Tetramethylcyclopentan-1-one | C9H16O | 56077-22-6 | Details |
| H-FQTKGLGISYGR-OH | Details |
| 2-(Hydroxymethyl)-2-(1H-1,2,3,4-tetrazol-1-yl)propane-1,3-diol | C5H10N4O3 | 103518-51-0 | Details |
| H-VLELTSDNDR-OH | Details |
| 2-(1H-1,3-Benzodiazol-2-yl)-1-(3-chlorophenyl)ethan-1-one | C15H11ClN2O | 554404-48-7 | Details |
| PGRMC2 antibody | Details |
| GCLM protein (His tag) | Details |
| 2,3-Di-O-benzoyl-a-cyclodextrin | C120H108O42 | 68715-47-9 | Details |
| 3-[4-(Cyclopropylmethyl)piperazin-1-yl]aniline | C14H21N3 | 1018649-76-7 | Details |
| 2-(2-{[(tert-Butoxy)carbonyl]amino}ethyl)-5-methyl-1,3-thiazole-4-carboxylic acid | C12H18N2O4S | 2095670-49-6 | Details |
| N-(4-Chlorophenyl)-2-sulfanyl-1,3-benzoxazole-5-sulfonamide | C13H9ClN2O3S2 | 379729-37-0 | Details |
| POLR1E Blocking Peptide | Details |
| 2-(2,6-Dioxopiperidin-3-yl)acetic acid | C7H9NO4 | 24866-83-9 | Details |
| 5-(3,4-Dimethoxybenzylidene)-2-thioxo-1,3-thiazolidin-4-one | C12H11NO3S2 | 948016-52-2 | Details |
| N-[(2,4-Dichloro-1-phenyl-1H-imidazol-5-yl)methylidene]hydroxylamine | C10H7Cl2N3O | 1181471-86-2 | Details |
| 6-Fluoro-4-methoxy-1,3-benzothiazol-2-amine | C8H7FN2OS | 1249139-53-4 | Details |
| DECR2 protein (His tag) | Details |
| Ac-Asp-Glu-Asp(EDANS)-Glu-Glu-Abu-L-lactoyl-Ser-Lys(DABCYL)-NH2 ammonium salt | C68H89N15O25S | 188530-20-3 | Details |
| 2-(2-Chlorophenyl)-1-(furan-3-yl)ethan-1-one | C12H9ClO2 | 1184371-84-3 | Details |
| Taurolithocholic acid | C26H45NO5S | 516-90-5 | Details |
| TPH2 Blocking Peptide | Details |
| Escitalopram antibody | Details |
| tert-Butyl N-{[2-(hydroxymethyl)spiro[3.3]heptan-2-yl]methyl}carbamate | C14H25NO3 | 2097963-98-7 | Details |
| 1-Phenylmethanesulfonylpyrrolidine-2-carboxylic acid | C12H15NO4S | 100391-96-6 | Details |
| 4-Benzyl-2-methyl-1-oxa-4,9-diazaspiro[5.5]undecane dihydrochloride | 2138180-89-7 | Details |
| Recombinant Viral CMV UL146 | Details |
| 1-(4-Methylphenyl)-6-oxo-1,4,5,6-tetrahydropyridazine-3-carboxylic acid | C12H12N2O3 | 926240-25-7 | Details |
| (-)-Epicatechin-pentaacetate | C25H24O11 | 20194-41-6 | Details |
| 1-(3-Cyanopropyl)-1H-1,2,3-triazole-4-carboxylic acid | C7H8N4O2 | 1423029-43-9 | Details |
| 2-(4-Chloro-3-fluorophenyl)-1-(2-methoxyethyl)-5-oxopyrrolidine-3-carboxylic acid | C14H15ClFNO4 | 1333577-80-2 | Details |
| Human MMP1 ELISA kit | Details |
| N-[2-[(2-Bromo-4,6-dinitrophenyl)azo]-5-(diethylamino)phenyl]acetamide | C18H19BrN6O5 | 52697-38-8 | Details |
| anti-GST Antibody (FITC) | Details |
| Methyl 4-hydroxyquinoline-3-carboxylate | C11H9NO3 | 38113-86-9 | Details |
| 5-(Chloromethyl)-2-phenylpyrimidine | C11H9ClN2 | 886531-63-1 | Details |
| H-VGNEIQYVALR^-OH | Details |
| Methyl 3-Iodoimidazo[1,2-a]pyridine-7-carboxylate | C9H7IN2O2 | 1009378-93-1 | Details |
| Product Total： Product Page： | ||||
| 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 | ||||